Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gary Gustavsen

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Personalized Medicine|May 23, 2018
Combating complexity: partnerships in personalized medicineKristin Pothier, Gary Gustavsen
Future Oncology (London, England)|September 9, 2020
Health economic impact of a biopsy-based cell cycle gene expression assay in localized prostate cancerGary Gustavsen, Kelsey Taylor, Doria Cole, et al.
Journal of Medical Economics|August 30, 2014
Budget impact analysis of a novel gene expression assay for the diagnosis of malignant melanomaDavid S Cassarino, Nicolas Lewine, Doria Cole, et al.
Future Oncology (London, England)|December 6, 2019
Economic burden of illness associated with localized prostate cancer in the United StatesGary Gustavsen, Laura Gullet, Doria Cole, et al.
Journal of Personalized Medicine|April 3, 2021
A Quantitative Framework for Measuring Personalized Medicine Integration into US Healthcare Delivery OrganizationsArushi Agarwal, Daryl Pritchard, Laura Gullett, et al.
Diagnostics (Basel, Switzerland)|October 29, 2025
Perceived Barriers to NGS-Based Molecular Profiling Among US Metastatic Breast Cancer PatientsNicholas Cadirov, Moumita Chaki, Olivia Foroughi, et al.
The American Journal of Managed Care|October 9, 2014
Health economic analysis of Breast Cancer Index in patients with ER+, LN- breast cancerGary Gustavsen, Brock Schroeder, Patrick Kennedy, et al.
Diagnostics (Basel, Switzerland)|October 16, 2025
Clinician Perspectives on Digital and Computational Pathology: Clinical Benefits, Concerns, and Willingness to AdoptCharu Aggarwal, Aakash Desai, Nicholas McConnell, et al.
Journal of Personalized Medicine|June 27, 2024
Perspectives on Clinical Adoption Barriers to Blood-Based Multi-Cancer Early Detection Tests across StakeholdersMonica M Schroll, Elissa Quinn, Daryl Pritchard, et al.
Diagnostics (Basel, Switzerland)|April 12, 2025
Perspectives on Reducing Barriers to the Adoption of Digital and Computational Pathology Technology by Clinical LabsJeffrey L Bessen, Melissa Alexander, Olivia Foroughi, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Personalized Medicine|May 23, 2018
Combating complexity: partnerships in personalized medicineKristin Pothier, Gary Gustavsen
Future Oncology (London, England)|September 9, 2020
Health economic impact of a biopsy-based cell cycle gene expression assay in localized prostate cancerGary Gustavsen, Kelsey Taylor, Doria Cole, et al.
Journal of Medical Economics|August 30, 2014
Budget impact analysis of a novel gene expression assay for the diagnosis of malignant melanomaDavid S Cassarino, Nicolas Lewine, Doria Cole, et al.
Future Oncology (London, England)|December 6, 2019
Economic burden of illness associated with localized prostate cancer in the United StatesGary Gustavsen, Laura Gullet, Doria Cole, et al.
Journal of Personalized Medicine|April 3, 2021
A Quantitative Framework for Measuring Personalized Medicine Integration into US Healthcare Delivery OrganizationsArushi Agarwal, Daryl Pritchard, Laura Gullett, et al.
Diagnostics (Basel, Switzerland)|October 29, 2025
Perceived Barriers to NGS-Based Molecular Profiling Among US Metastatic Breast Cancer PatientsNicholas Cadirov, Moumita Chaki, Olivia Foroughi, et al.
The American Journal of Managed Care|October 9, 2014
Health economic analysis of Breast Cancer Index in patients with ER+, LN- breast cancerGary Gustavsen, Brock Schroeder, Patrick Kennedy, et al.
Diagnostics (Basel, Switzerland)|October 16, 2025
Clinician Perspectives on Digital and Computational Pathology: Clinical Benefits, Concerns, and Willingness to AdoptCharu Aggarwal, Aakash Desai, Nicholas McConnell, et al.
Journal of Personalized Medicine|June 27, 2024
Perspectives on Clinical Adoption Barriers to Blood-Based Multi-Cancer Early Detection Tests across StakeholdersMonica M Schroll, Elissa Quinn, Daryl Pritchard, et al.
Diagnostics (Basel, Switzerland)|April 12, 2025
Perspectives on Reducing Barriers to the Adoption of Digital and Computational Pathology Technology by Clinical LabsJeffrey L Bessen, Melissa Alexander, Olivia Foroughi, et al.
Pageof 2